Journal article
Adenylyl cyclase isoform 1 contributes to sinoatrial node automaticity via functional microdomains
- Abstract:
- Sinoatrial node (SAN) cells are the heart's primary pacemaker. Their activity is tightly regulated by β-adrenergic receptor (β-AR) signaling. Adenylyl cyclase (AC) is a key enzyme in the β-AR pathway that catalyzes the production of cAMP. There are current gaps in our knowledge regarding the dominant AC isoforms and the specific roles of Ca2+-activated ACs in the SAN. The current study tests the hypothesis that distinct AC isoforms are preferentially expressed in the SAN and compartmentalize within microdomains to orchestrate heart rate regulation during β-AR signaling. In contrast to atrial and ventricular myocytes, SAN cells express a diverse repertoire of ACs, with ACI as the predominant Ca2+-activated isoform. Although ACI-KO (ACI-/-) mice exhibit normal cardiac systolic or diastolic function, they experience SAN dysfunction. Similarly, SAN-specific CRISPR/Cas9-mediated gene silencing of ACI results in sinus node dysfunction. Mechanistically, hyperpolarization-activated cyclic nucleotide-gated 4 (HCN4) channels form functional microdomains almost exclusively with ACI, while ryanodine receptor and L-type Ca2+ channels likely compartmentalize with ACI and other AC isoforms. In contrast, there were no significant differences in T-type Ca2+ and Na+ currents at baseline or after β-AR stimulation between WT and ACI-/- SAN cells. Due to its central characteristic feature as a Ca2+-activated isoform, ACI plays a unique role in sustaining the rise of local cAMP and heart rates during β-AR stimulation. The findings provide insights into the critical roles of the Ca2+-activated isoform of AC in sustaining SAN automaticity that is distinct from contractile cardiomyocytes
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 15.4MB, Terms of use)
-
- Publisher copy:
- 10.1172/jci.insight.162602
Authors
+ American Heart Association
More from this funder
- Funder identifier:
- 10.13039/100000968
- Grant:
- 18PRE34030199
+ U.S. Department of Veterans Affairs
More from this funder
- Funder identifier:
- 10.13039/100000738
- Grant:
- I01 BX000576,I01 CX001490
+ British Heart Foundation
More from this funder
- Funder identifier:
- 10.13039/501100000274
- Grant:
- PG/15/5/31110,RG/17/6/32944
+ National Institutes of Health
More from this funder
- Funder identifier:
- 10.13039/100000002
- Grant:
- NIH R01 HL085844,NIH R01 HL137228,NIH S10 OD010389,NIH R01 HL085727,NIH T32 HL086350,NIH F32 HL149288,NIH R56 HL138392,NIH P01 AG051443,NIH R01 DC015252,NIH R01 DC015135,NIH HL147263,NIH R01HL098200,R01HL149127
- Publisher:
- American Society for Clinical Investigation
- Journal:
- JCI Insight More from this journal
- Volume:
- 7
- Issue:
- 22
- Pages:
- e162602
- Article number:
- e162602
- Publication date:
- 2022-11-21
- DOI:
- EISSN:
-
2379-3708
- ISSN:
-
2379-3708
- Language:
-
English
- Keywords:
- Pubs id:
-
1316645
- Local pid:
-
pubs:1316645
- Source identifiers:
-
W4309497287
- Deposit date:
-
2026-04-30
- ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.
Terms of use
- Copyright date:
- 2022
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record